Critical values ofr therapuetuic drug levels The concept of critical vlaues for drug levels was developed by Daniel M. Baer, MD, professor emertius of laboratory medicine, Oregon Health Sciences University, Portland, OR, and first published in the April 1982 issue of MLO. This table is anexpanded version of that publication newly revised this year by Sue Millar, PharmD. Dr. Baer is a member of MLO's Editorial Board and editor of MLO's "Tips from the Clinical Expets" department. Drug Therapeutic range ANTIBIOTICS (Specimen collection depends on the the dosing protocol followed. Consult the hospital pharmacy). Gentamycin 6-10 mcg/mL peak Tobramycin 6-10 mcg/mL peak Amikacin 15-30 mcg/mL peak [less than]10mcg/mL trough Vancomycin 20-40 mcg/mL peak 5-15 mcg/mL trough ANALGESICS (Specimen collection: For toxic ingestion, draw sample at any time, noting times of ingestion and sample collection. Usually two samples, several hours apart, acted to determine half-life.) Acetaminophen 5-20 mcg/mL Salicylate 10-20 mg/dL ANTIEPILEPTICS (Specimen collection: Trough, before next dose. Several samples should be drawn at the same time each day.) Carbamazepine * 4-12 mcg/mL Ehtosuximide 40-100 mcg/mL Phenobarbitol 15-40 mcg/mL Phenytoin 10-20 mcg/mL Primidone 5-12 mcg/mL Valproic acid 50-100 mcg/mL ANTIDEPRESSANTS Lithium specimen collection: 12 hours after dose Lithium (acute) 1.0-1.6 mEq/L Lithium (chronic) 0.5-1.0 mEq/L Specimen collection: Trough, before next dose Amitriptyline 120-125 ng/mL * Imipramine 150-300 ng/mL Nortriptyline 50-150 ng/mL Protriptyline 70-240 ng/mL Doxepin 150-300 ng/mL * OTHER DRUGS Cyclosporin 150-400 ng/mL 100-200 mcg/mL Theophylline 10-20 mcg/mL Digoxin 0.5-2.0 ng/mL Drug Critical value ANTIBIOTICS (Specimen collection depends on the the dosing protocol followed. Consult the hospital pharmacy). Gentamycin [greater than] 12 mcg/mL peak Tobramycin [greater than] 12 mcg/mL peak Amikacin [greater than] 10 mcg/mL trough Vancomycin 60-80 mcg/mL peak ANALGESICS (Specimen collection: For toxic ingestion, draw sample at any time, noting times of ingestion and sample collection. Usually two samples, several hours apart, acted to determine half-life.) Acetaminophen 150 mcg/mL Salicylate [greater than] 30 mg/dL ANTIEPILEPTICS (Specimen collection: Trough, before next dose. Several samples should be drawn at the same time each day.) Carbamazepine * [greater than] 20 mcg/mL Ehtosuximide [greater than] 200 mcg/mL Phenobarbitol [greater than] 60 mcg/mL Phenytoin [greater than] 40 mcg/mL Primidone [greater than] 24 mcg/mL Valproic acid [greater than] 200 mcg/mL ANTIDEPRESSANTS Lithium specimen collection: 12 hours after dose Lithium (acute) [greater than] 2.0 mEq/L Lithium (chronic) Specimen collection: Trough, before next dose Amitriptyline 400 ng/mL * Imipramine 400 ng/mL Nortriptyline 200 ng/mL Protriptyline 400 ng/mL Doxepin 400 ng/mL * OTHER DRUGS Cyclosporin Theophylline [greater than]25 mcg/mL Digoxin 2.5 ng/mL Drug Comment ANTIBIOTICS (Specimen collection depends on the the dosing protocol followed. Consult the hospital pharmacy). Gentamycin These values correlatee only with standard dosing, not pulse or single daily dosing. Tobramycin Toxicity is related to trough concentrations and time spent at that concentration. Several methods for single daily dosing exist. Depending on the method, timing of drawing levels and desired levels will vary. Amikacin Vancomycin Draw peak 2-3 hrs after infusion ends. Peak concentrations not correlated with clinical efficacy. Toxicity is correlated with very high levels (60-80) mcg/mL) or duration of therapy. Draw trough immediately before next dose. ANALGESICS (Specimen collection: For toxic ingestion, draw sample at any time, noting times of ingestion and sample collection. Usually two samples, several hours apart, acted to determine half-life.) Acetaminophen To be measured 4 hours after the Salicylate last dose. ANTIEPILEPTICS (Specimen collection: Trough, before next dose. Several samples should be drawn at the same time each day.) Carbamazepine * Toxicity is usually clinically evident. Serious toxicity is likely at twice the upper therapeutic level. Ehtosuximide Phenobarbitol Phenytoin Primidone Valproic acid ANTIDEPRESSANTS Lithium specimen collection: 12 hours after dose Lithium (acute) Level over 5 mEq/L are potentially lethal. Lithium (chronic) Specimen collection: Trough, before next dose Amitriptyline Life-threatening cardiac toxicity or seizures are seen if concentration is over 1,000 ng/mL Imipramine Nortriptyline Protriptyline Doxepin OTHER DRUGS Cyclosporin Monoclonal immunoassay. Sampling at a few time points may provide more cost-effective monitoring. Levels will vary based on whether taken from whole blood, serum, or plasma. High-performance liquid chromatography. Theophylline Above this concentration, 75% of patients have toxic symtpoms. Serious toxicity causes seizures that can be fatal. Draw sample at peak. Different theophylline timed release medications have peaks at different times. Medication package insert should be consulted. Serial measurements should be collected at the same time each day. Digoxin Eighty-seven percent of patients with greater than 2 ng/mL digoxin have toxic symptoms. (*) 4-8 if patient is on multiple antiepileptic drugs (*) Parent drug plus demethylated metabolite Proper interpretation of therapeutic drug concentrations requires that the specimen be drawn at an appropriate time in relation to drug administration.